>2 million

Since its creation in 2013, the global oral cholera vaccine stockpile has been used to vaccinate more than 2 million people. In 2016, eight countries – the Democratic Republic of the Congo, Haiti, Mozambique, Malawi, Niger, Somalia, South Sudan and Zambia – accessed the stockpile.

Source: Gavi

>100 million

Since 2011, Gavi-supported yellow fever campaigns have protected over 98 million people in 14 countries. We have also helped 17 countries introduce yellow fever vaccine through routine immunisation, immunising more than 100 million children.

Source: Gavi

41 million

Since 2007, countries have immunised 41 million children with a second dose of measles or measles-rubella vaccine with Gavi support. Gavi-funded campaigns with these two vaccines have helped vaccinate another 328 million children in countries at high risk of outbreaks.

Source: WHO/UNICEF and Gavi, 2017

40 million

In September 2014, Nepal became the first country to introduce inactivated polio vaccine (IPV) with Gavi support. By the end of 2016, 54 countries had introduced the vaccine with our support, collectively immunising more than 40 million children.

Source: Gavi

>60

The Vaccine Alliance has helped to strengthen health systems and immunisation services in more than 60 countries.

Source: Gavi

62 million

In 2016 alone, 62 million children were immunised with Gavi-supported vaccines. This equates to more than 185 million points of contact between these children and the primary health system and provides a robust platform for other health interventions.

Source: WHO/UNICEF 2017

US$ 80-100 billion

Investing in Gavi’s 2016-2020 strategy has the potential to deliver US$ 80-100 billion in costs averted related to illness, such as productivity loss due to death/disability, treatment costs, caretaker productivity loss and transport costs.

Source: Stack M et al. Estimated economic benefits during Decade of Vaccines, Health Affairs 2011

>1 million

Since the first human papillomavirus (HPV) vaccine demonstration programme in Kenya in 2013, over 1 million girls have been immunised with Gavi support.

Source: Gavi

>380

Gavi has supported over 380 vaccine introductions and campaigns since 2000.

Source: Gavi

19.5 million

19.5 million infants remain underimmunised with three doses of DTP in the world each year. One in five of all children in Gavi-supported countries miss out on a full course of this basic package of vaccines.

Source: WHO/UNICEF 2017

1.5 million

In 2012, approximately 6.6 million children died before the age of five. WHO estimates that 1.5 million of these deaths are due to vaccine-preventable diseases.

Source: WHO

48%

The weighted average price of pentavalent vaccine per dose dropped from US$ 2.98 in 2010 to US$ 1.55 in 2016, and is expected to decrease further to US$ 0.79 by 2019.

Source: Gavi

US$ 1 = US$ 18

A study in Health Affairs covering 73 Gavi-supported countries over the 2011–2020 period shows that, for every US$ 1 spent on immunisation, US$ 18 are saved in healthcare costs, lost wages and lost productivity due to illness. If we take into account the broader benefits of people living longer, healthier lives, the return on investment rises to US$ 48 per US$ 1 spent.

Source: Ozawa S, Clark S, Portnoy A et al. Return on investment from childhood immunizations in low- and middle-income countries, 2011-20, Health Affairs 2016.

>109 million

By the end of 2016, 57 countries had immunised more than 109 million children against pneumococcal disease with support from the Vaccine Alliance.

Source: WHO/UNICEF 2017

Close to 640 million

Since 2000, Gavi support has contributed to the immunisation of close to 640 million children.

Source: WHO/UNICEF 2017

Every two minutes

One woman dies from cervical cancer every two minutes – or 266,000 a year – over 85% in the developing world. If current trends hold, and without changes in prevention and control, cervical cancer deaths could eventually outpace maternal deaths. HPV vaccines can prevent up to 90% of all cervical cancer cases.

Source: WHO

7%

Only 7% of children in Gavi-supported countries have access to all 11 vaccines recommended by WHO for infants in all countries.

Source: WHO/UNICEF, UNDP 2017

>268 million

By the end of 2016, 19 countries in the African meningitis belt had immunised over 268 million people against meningitis A with Gavi support.

Source: WHO/UNICEF and Gavi 2017

20 by 2020

Gavi continues to help countries to build sustainable immunisation programmes. Sixteen countries have already started to fully self-finance all their vaccines introduced with Gavi funding. By the end of 2020, a total of 20 countries are expected to have transitioned out of our support.

Source: Gavi

>9 million

Since its inception in 2000, Gavi has helped developing countries to prevent more than 9 million future deaths through its support for routine immunisation programmes and vaccination campaigns.

Source: WHO/UNICEF and Gavi, 2017

close icon

modal window here